検索結果

Search Results for " KRAS "

ターゲット

202

阻害剤

天然化合物

リコンビナントタンパク質

ライブラリー

カタログ番号	製品名	別名	ターゲット
T8756	KRAS inhibitor-9	DUN09716	Apoptosis , Ras
	KRAS inhibitor-9 (DUN09716) is a potent KRAS inhibitor with Kd of 92 μM that blocks the formation of GTP-KRAS and downstream activation of KRAS. KRAS inhibitor-9 causes G2/M cell cycle arrest and induces apoptosis. KRAS ...		Apoptosis , Ras
T40286	KRAS G12C inhibitor 19		Ras
	KRAS G12C inhibitor 19 is a potent KRAS G12C inhibitor that shows anti-tumor activity in cellular assays, and the family inhibits tumor growth.		Ras
T78212	RMC-9805	KRAS G12D inhibitor 18,KRAS G12D IN 18	Others
	RMC-9805 is a potent KRAS G12D inhibitor with potential anti-tumor and inhibitory activity against tumor cell proliferation for the study of pancreatic cancer.		Others
T38936	KRAS G13D peptide, 25 mer	KRAS G13D peptide, 25 mer
	KRAS G13D peptide, a 25-mer sequence, is derived from the KRAS activating oncogene mutation and serves as an immune potentiator. This peptide possesses immunogenic properties and can be utilized for the development of a ...
T36761	KRAS inhibitor-10
	KRAS inhibitor-10 (WO2021005165 A1, compound 11) is a potent and selective inhibitor of RAS proteins, with a specific focus on KRAS proteins. This orally active anti-cancer agent demonstrates strong efficacy in cancer re...
T40282	KRAS G12D inhibitor 7
	KRAS G12D inhibitor 7, is a highly potent inhibitor specifically targeting KRAS G12D.
T77806	KRAS inhibitor FB9
	KRAS inhibitor FB9 can be used in studies about Ras.
T40281	KRAS G12D inhibitor 6
	KRAS G12D inhibitor 6 is an efficacious compound that effectively inhibits KRAS G12D.
T40246	KRAS G12D inhibitor 5
	KRAS G12D inhibitor 5 is a KRAS G12D inhibitor for the potential treatment of pancreatic cancer.
T11774	KRAS inhibitor-7		Ras
	KRAS inhibitor-7 is a potent KRAS G12C inhibitor.		Ras
T11775	KRAS inhibitor-8		Ras
	KRAS inhibitor-8 is a potent KRAS G12C inhibitor.		Ras
T9674	KRAS G12D inhibitor 1
	KRAS G12D inhibitor 1 (example 243) is an inhibitor of KRAS G12D with an IC 50 of 0.8 nM for KRAS G12D-mediated ERK phosphorylation [1].
T40285	KRAS G12C inhibitor 18
	KRAS G12C inhibitor 18 is a potent, orally active compound that inhibits KRAS G12C and exhibits anti-tumor activities.
T77808	Kras binder 12
	Kras binder 12 can be used in studies about Ras.
T11773	KRAS inhibitor-6		Ras
	KRAS inhibitor-6 is a potent KRAS G12C inhibitor.		Ras
T11772	KRAS inhibitor-4		Others
	KRAS inhibitor-4 developed as anticancer agents, is a potent KRAS inhibitor.		Others
T11769	KRAS G12C inhibitor 15		Ras
	KRAS G12C inhibitor 15 is a potent KRAS G12C inhibitor .		Ras
T11768	KRAS G12C inhibitor 14		Ras
	KRAS G12C inhibitor 14 is a potent KRAS G12C inhibitor with an IC 50 of 18 nM [1].		Ras
T11778	KRas G12C inhibitor 3		Ras
	KRas G12C inhibitor 3 is a compound that inhibits KRas G12C.		Ras
T11780	KRAS G12C inhibitor 5		Ras
			Ras
T40272	KRAS mutant protein inhibitor 1
	KRAS mutant protein inhibitor 1 is a KRAS mutant protein inhibitor for potential treatment in cancer.
T11767	KRAS G12C inhibitor 13		Ras
	KRAS G12C inhibitor 13 is a KRAS G12C inhibitor .		Ras
T11779	KRas G12C inhibitor 4		Ras
	KRas G12C inhibitor 4 is a compound that inhibits KRas G12C.		Ras
T11776	KRas G12C inhibitor 1		Ras
	KRas G12C inhibitor 1 is a compound that inhibits KRas G12C.		Ras
T77802	KRAS G12C inhibitor 1R
	KRAS G12C inhibitor 1R can be used in studies about Ras.
T77804	KRAS G12D mutation regulator 4
	KRAS G12D mutation regulator 4 can be used in studies about Ras.
T11771	KRAS G12C inhibitor 17		Ras
	KRAS G12C inhibitor 17 is a potent KRAS G12C inhibitor.		Ras
T11770	KRAS G12C inhibitor 16		Ras
	KRAS G12C inhibitor 16 is a potent KRAS G12C inhibitor.		Ras
T11777	KRas G12C inhibitor 2		Ras
	KRas G12C inhibitor 2 is a compound that inhibits KRas G12C.		Ras
T77805	KRAS G12C mutant protein inhibitor A-1
	KRAS G12C mutant protein inhibitor A-1 can be used in studies about Ras.
T72599	KRAS inhibitor-11
	KRAS inhibitor-11 is a KRAS inhibitor .
T62737	KRAS inhibitor-15
	KRAS inhibitor-15 (compound 3-19) is a potent inhibitor of KRAS G12C (IC50: 0.954 μM). KRAS inhibitor-15 exhibits p-ERK inhibition in MIA PaCA-2, A549 cells with IC50s of 2.03, >33.3 μM, respectively. KRAS inhibitor-15 h...
T63164	KRAS inhibitor-13
	KRAS inhibitor-13 (compound 5-6) is a potent inhibitor of KRAS G12C (IC50: 0.883 μM). KRAS inhibitor-13 has a p-ERK inhibitory effect in MIA PaCA-2, A549 cells with IC50 values of 5.9 and >100 μM respectively. KRAS inhib...
T62751	KRAS inhibitor-12
	KRAS inhibitor-12 (compound 6-1) is a potent inhibitor of KRAS G12C (IC50: 0.537 μM). KRAS inhibitor-12 exhibits p-ERK inhibition in MIA PaCA-2, A549 cells with IC50 values of 1.3, 3.7 μM respectively. KRAS inhibitor-12 ...
T79147	KRAS degrader-1
	KRAS degrader-1 (compound 1) is a potent agent that selectively targets KRAS proteins for destruction via the autophagy-lysosomal degradation pathway [1].
T72659	KRAS inhibitor-3
	KRAS inhibitor-3, an efficacious inhibitor of both wild-type (WT) and oncogenic KRAS mutations, exhibits high-affinity binding (K D: 0.28 μM for KRAS WT, 0.63 μM for KRAS G12C, 0.37 μM for KRAS G12D, and 0.74 μM for KRAS...
T63928	KRAS inhibitor-21
	KRAS inhibitor-21 (22b) is a KRAS G12C inhibitor (IC50<0.01 μM) that can be used in cancer research.
T62752	KRAS inhibitor-16
	KRAS inhibitor-16 (compound 3-11) is a potent inhibitor of KRAS G12C (IC50: 0.457 μM). KRAS inhibitor-16 exhibits p-ERK inhibition in MIA PaCA-2, A549 cells with IC50s of 3.06, 11.1 μM respectively. KRAS inhibitor-16 has...
T62784	KRAS inhibitor-18
	KRAS inhibitor-18 (compound 3-10) is a potent inhibitor of KRAS G12C (IC50: 4.74 μM). KRAS inhibitor-18 exhibited p-ERK inhibition in MIA PaCA-2, A549 cells with IC50s of 66.4, 11.1 μM respectively. KRAS inhibitor-18 has...
T63235	KRAS inhibitor-14
	KRAS inhibitor-14 is a potent inhibitor of KRAS G12C (IC50: 0.249 μM). KRAS inhibitor-14 exhibited p-ERK inhibition in MIA PaCA-2, A549 cells with IC50s of 1.12, >33.3 μM, respectively. KRAS inhibitor-14 has potential to...
T62981	KRAS inhibitor-17
	KRAS inhibitor-17 (compound 3-9) is a potent inhibitor of KRAS G12C (IC50: 3.37 μM). KRAS inhibitor-17 exhibits p-ERK inhibition with IC50 = 9.25 μM in MIA PaCA-2 cells and >33.3 μM in A549 cells. KRAS inhibitor-17 has t...
T62228	KRAS G12D inhibitor 14		Ras
	KRAS G12D inhibitor 14 is a potent inhibitor of KRAS G12D that binds KRAS G12D protein (Kd: 33 nM). KRAS G12D inhibitor 14 inhibits the active form of KRAS G12D (KRAS G12D-GTP), but not KRAS G13D.		Ras
T79799	Pan-KRAS-IN-4		Ras
	Pan-KRAS-IN-4 (compound 5) is a potent KRAS inhibitor, demonstrating IC50 values of 0.37 nM for Kras G12C and 0.19 nM for Kras G12V [1].		Ras
T63927	KRAS G12C inhibitor 25
	KRAS G12C inhibitor 25 is an inhibitor of KRAS G12C. KRAS G12C inhibitor 25 inhibits the SOS1-assisted GDP/GTP exchange activity of KRAS-G12C mutants with an IC50 value of 0.48 nM.
T62566	KRAS G12C inhibitor 53
	KRAS G12C inhibitor 53 (Compound 1) is a KRAS G12C inhibitor.
T64095	KRAS G12C inhibitor 42
	KRAS G12C inhibitor 42 is a potent inhibitor of KRAS G12C. KRAS G12C inhibitor 42 has shown potential for the investigation of KRAS G12C-mediated cancers.
T79162	SOS1/KRAS-IN-1		Ras
	SOS1/KRAS-IN-1 (Compound 2) serves as an inhibitor of SOS1/KRAS, with potential application in the study of diseases mediated by SOS1/KRAS [1].		Ras
T63577	KRAS G12D inhibitor 11
	KRAS G12D inhibitor 11 is a potent inhibitor of KRAS G12D. The Ras family of proteins are important intracellular signaling molecules that play an important role in growth and development, and KRAS G12D inhibitor 11 has ...
T63502	KRAS G12C inhibitor 31
	KRAS G12C inhibitor 31 is an inhibitor of KRAS G12C that can be used to study cancer.
T72335	KRAS G12C inhibitor 32		Ras
	KRAS G12C Inhibitor 32, an eight-membered heterocyclic compound with nitrogen, acts as a potent inhibitor of KRAS G12C [1].		Ras

Compounds

KRAS inhibitor-9

T8756

Synonym: DUN09716

Target: Apoptosis, Ras

KRAS G12C inhibitor 19

Synonym: KRAS G12D inhibitor 18,KRAS G12D IN 18

Target: Others

KRAS G13D peptide, 25 mer

T38936

Synonym: KRAS G13D peptide, 25 mer

KRAS G12D inhibitor 7

KRAS G12D inhibitor 6

T40281

Synonym:

Target:

KRAS G12D inhibitor 5

KRAS G12D inhibitor 1

T9674

Synonym:

Target:

KRAS G12C inhibitor 18

KRAS G12C inhibitor 15

T11769

Synonym:

Target: Ras

KRAS G12C inhibitor 14

T11768

Synonym:

Target: Ras

KRas G12C inhibitor 3

T11778

Synonym:

Target: Ras

KRAS G12C inhibitor 5

T11780

Synonym:

Target: Ras

KRAS mutant protein inhibitor 1

T40272

Synonym:

Target:

KRAS G12C inhibitor 13

T11767

Synonym:

Target: Ras

KRas G12C inhibitor 4

T11779

Synonym:

Target: Ras

KRas G12C inhibitor 1

T11776

Synonym:

Target: Ras

KRAS G12C inhibitor 1R

T77802

Synonym:

Target:

KRAS G12D mutation regulator 4

T77804

Synonym:

Target:

KRAS G12C inhibitor 17

T11771

Synonym:

Target: Ras

KRAS G12C inhibitor 16

T11770

Synonym:

Target: Ras

KRas G12C inhibitor 2

T11777

Synonym:

Target: Ras

KRAS G12C mutant protein inhibitor A-1

KRAS G12D inhibitor 14

KRAS G12C inhibitor 25

T63927

Synonym:

Target:

KRAS G12C inhibitor 53

T62566

Synonym:

Target:

KRAS G12C inhibitor 42

KRAS G12D inhibitor 11

T63577

Synonym:

Target:

KRAS G12C inhibitor 31

T63502

Synonym:

Target:

KRAS G12C inhibitor 32

T72335

Synonym:

Target: Ras

カタログ番号	製品名	別名	ターゲット
T5S0777	Phellodendrine chloride		Others
	Phellodendrine chloride has anti-nephritic activity, may be due to its ability to inhibit the proliferation or the migration of macrophages and cytotoxic T lymphocytes in the glomeruli.		Others

天然物製品

Phellodendrine chloride

T5S0777

Synonym:

Target: Others

Recombinant Proteins

Species：

Expression System：

Tag：

カタログ番号	製品名	Species	Expression System
TMPY-04113	KRAS Protein,Human,Recombinant(G12D & Q61H, His)	Human	E. coli
	KRAS Protein,Human,Recombinant(G12D & Q61H, His) is expressed in E. coli expression system with His tag. The predicted molecular weight is 23.3 kDa and the accession number is P01116-2.
TMPY-06056	KRAS Protein, Human, Recombinant (G12D, His)	Human	E. coli
	KRAS Protein, Human, Recombinant (G12D, His) is expressed in E. coli expression system with His tag. The predicted molecular weight is 22 kDa and the accession number is P01116-2.
TMPY-01888	KRAS Protein,Human, Recombinant (Q61H, His)	Human	E. coli
	KRAS Protein,Human, Recombinant (Q61H, His) is expressed in E. coli expression system with His tag. The predicted molecular weight is 22.5 kDa and the accession number is P01116-2.
TMPY-04116	KRAS Protein,Human,Recombinant(G12C & Q61H, His)	Human	E. coli
	KRAS Protein,Human,Recombinant(G12C & Q61H, His) is expressed in E. coli expression system with His tag. The predicted molecular weight is 23.3 kDa and the accession number is P01116-2.
TMPK-01451	HLA-C 03:04&B2M&KRAS G12D (GADGVGKSAL) Monomer Protein, Human, MHC (His & Avi)	Human	HEK293 Cells
	Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-pr...
TMPK-01432	HLA-A11:01&B2M&KRAS* G12A (VVVGAAGVGK) Tetramer Protein, Human, MHC (His & Avi)	Human	HEK293 Cells
	Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-pr...
TMPK-01526	HLA-A03:01&B2M&KRAS* G12V (VVVGAVGVGK) Tetramer Protein, Human, MHC (His & Avi)	Human	HEK293 Cells
	Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-pr...
TMPK-01428	HLA-A11:01&B2M&KRAS* G12D (VVGADGVGK) Monomer Protein, Human, MHC (His & Avi)	Human	E. coli
	Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-pr...
TMPK-01461	HLA-A11:01&B2M&KRAS* G12S (VVVGASGVGK) Monomer Protein, Human, MHC (His & Avi)	Human	HEK293 Cells
	Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-pr...
TMPK-01433	HLA-A11:01&B2M&KRAS* G12C (VVVGACGVGK) Tetramer Protein, Human, MHC (His & Avi)	Human	HEK293 Cells
	Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-pr...
TMPK-01450	HLA-C03:04&B2M&KRAS* G12D (GADGVGKSAL) Monomer Protein, Human, MHC (His & Avi), Biotinylated	Human	HEK293 Cells
	Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-pr...
TMPK-01457	HLA-A11:01&B2M&KRAS* G12A (VVVGAAGVGK) Monomer Protein, Human, MHC (His & Avi), Biotinylated	Human	HEK293 Cells
	Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-pr...
TMPK-01453	HLA-A03:01&B2M&KRAS* G12V (VVVGAVGVGK) Monomer Protein, Human, MHC (His & Avi), Biotinylated	Human	HEK293 Cells
	Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-pr...
TMPK-01537	HLA-A11:01&B2M&KRAS* G12D (VVVGADGVGK) Monomer Protein, Human, MHC (His & Avi), Biotinylated	Human	HEK293 Cells
	Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-pr...
TMPK-01439	HLA-A11:01&B2M&KRAS* G12D (VVVGADGVGK) Tetramer Protein, Human, MHC (His & Avi), PE-Labeled	Human	HEK293 Cells
	Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-pr...
TMPK-01528	HLA-A11:01&B2M&KRAS* G12V (VVVGAVGVGK) Monomer Protein, Human, MHC (His & Avi)	Human	HEK293 Cells
	Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-pr...
TMPK-01458	HLA-A11:01&B2M&KRAS* G12A (VVVGAAGVGK) Monomer Protein, Human, MHC (His & Avi)	Human	HEK293 Cells
	Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-pr...
TMPK-01463	HLA-A11:01&B2M&KRAS* G12C (VVVGACGVGK) Monomer Protein, Human, MHC (His & Avi)	Human	HEK293 Cells
	Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-pr...
TMPK-01434	HLA-A11:01&B2M&KRAS* G12R (VVVGARGVGK) Tetramer Protein, Human, MHC (His & Avi)	Human	HEK293 Cells
	Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-pr...
TMPK-01465	HLA-A11:01&B2M&KRAS* G12R (VVVGARGVGK) Monomer Protein, Human, MHC (His & Avi)	Human	HEK293 Cells
	Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-pr...
TMPK-01489	HLA-A11:01&B2M&KRAS* WT (VVVGAGGVGK) Tetramer Protein, Human, MHC (His & Avi)	Human	HEK293 Cells
	Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-pr...
TMPK-01512	HLA-A03:01&B2M&KRAS* WT (VVVGAGGVGK) Monomer Protein, Human, MHC (His & Avi)	Human	HEK293 Cells
	Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-pr...
TMPK-01488	HLA-A11:01&B2M&KRAS* WT (VVVGAGGVGK) Monomer Protein, Human, MHC (His & Avi)	Human	HEK293 Cells
	Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-pr...
TMPK-01404	HLA-A11:01&B2M&KRAS* G12V (VVVGAVGVGK) Monomer Protein, Human, MHC (E. coli, His & Avi), Biotinylated	Human	E. coli
	Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-pr...
TMPK-01408	HLA-A02:01&B2M&KRAS* G12V (KLVVVGAVGV) Monomer Protein, Human, MHC (His & Avi), Biotinylated	Human	E. coli
	Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-pr...
TMPK-01427	HLA-A11:01&B2M&KRAS* G12D (VVGADGVGK) Monomer Protein, Human, MHC (His & Avi), Biotinylated	Human	E. coli
	Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-pr...
TMPK-01464	HLA-A11:01&B2M&KRAS* G12R (VVVGARGVGK) Monomer Protein, Human, MHC (His & Avi), Biotinylated	Human	HEK293 Cells
	Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-pr...
TMPK-01525	HLA-A11:01&B2M&KRAS* G12V (VVGAVGVGK) Monomer Protein, Human, MHC (His & Avi), Biotinylated	Human	HEK293 Cells
	Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-pr...
TMPK-01399	HLA-A11:01&B2M&KRAS* WT (VVGAGGVGK) Monomer Protein, Human, MHC (His & Avi), Biotinylated	Human	E. coli
	Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-pr...
TMPK-01490	HLA-A11:01&B2M&KRAS* G12V (VVGAVGVGK) Monomer Protein, Human, MHC (His & Avi)	Human	HEK293 Cells
	Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-pr...
TMPK-01527	HLA-A03:01&B2M&KRAS* G12V (VVVGAVGVGK) Monomer Protein, Human, MHC (His & Avi)	Human	HEK293 Cells
	Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-pr...
TMPK-01431	HLA-A11:01&B2M&KRAS* G12S (VVVGASGVGK) Tetramer Protein, Human, MHC (His & Avi)	Human	HEK293 Cells
	Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-pr...
TMPK-01507	HLA-A11:01&B2M&KRAS* G12D (VVVGADGVGK) Tetramer Protein, Human, MHC (His & Avi)	Human	HEK293 Cells
	Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-pr...
TMPK-01529	HLA-A11:01&B2M&KRAS* G12D (VVVGADGVGK) Monomer Protein, Human, MHC (His & Avi)	Human	HEK293 Cells
	Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-pr...
TMPK-01456	HLA-C03:04&B2M&KRAS* G12D (GADGVGKSAL) Tetramer Protein, Human, MHC (His & Avi)	Human	HEK293 Cells
	Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-pr...
TMPK-01518	HLA-A11:01&B2M&KRAS* G12V (VVVGAVGVGK) Tetramer Protein, Human, MHC (His & Avi)	Human	HEK293 Cells
	Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-pr...
TMPK-01510	HLA-A03:01&B2M&KRAS* WT (VVVGAGGVGK) Tetramer Protein, Human, MHC (His & Avi)	Human	HEK293 Cells
	Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-pr...
TMPK-01430	HLA-A11:01&B2M&KRAS* G12D (VVVGADGVGK) Monomer Protein, Human, MHC (E. coli, His & Avi)	Human	E. coli
	Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-pr...
TMPK-01403	HLA-A11:01&B2M&KRAS* G12V (VVGAVGVGK) Monomer Protein, Human, MHC (E. coli, His & Avi)	Human	E. coli
	Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-pr...
TMPK-01443	HLA-A11:01&B2M&KRAS* G12V (VVVGAVGVGK) Monomer Protein, Human, MHC (His & Avi), FITC-Labeled	Human	HEK293 Cells
	Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-pr...
TMPK-01435	HLA-A03:01&B2M&KRAS* G12V (VVVGAVGVGK) Tetramer Protein, Human, MHC (His & Avi), PE-Labeled	Human	HEK293 Cells
	Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-pr...
TMPK-01471	HLA-A11:01&B2M&KRAS* WT (VVVGAGGVGK) Monomer Protein, Human, MHC (His & Avi), FITC-Labeled	Human	HEK293 Cells
	Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-pr...
TMPK-01460	HLA-A11:01&B2M&KRAS* G12S (VVVGASGVGK) Monomer Protein, Human, MHC (His & Avi), Biotinylated	Human	HEK293 Cells
	Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-pr...
TMPK-01536	HLA-A11:01&B2M&KRAS* G12V (VVVGAVGVGK) Monomer Protein, Human, MHC (His & Avi), Biotinylated	Human	HEK293 Cells
	Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-pr...
TMPK-01462	HLA-A11:01&B2M&KRAS* G12C (VVVGACGVGK) Monomer Protein, Human, MHC (His & Avi), Biotinylated	Human	HEK293 Cells
	Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-pr...
TMPK-01407	HLA-A02:01&B2M&KRAS* WT (KLVVVGAGGV) Monomer Protein, Human, MHC (His & Avi), Biotinylated	Human	E. coli
	Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-pr...
TMPK-01479	HLA-A11:01&B2M&KRAS* WT (VVVGAGGVGK) Monomer Protein, Human, MHC (His & Avi), Biotinylated	Human	HEK293 Cells
	Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-pr...
TMPK-01511	HLA-A03:01&B2M&KRAS* WT (VVVGAGGVGK) Monomer Protein, Human, MHC (His & Avi), Biotinylated	Human	HEK293 Cells
	Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-pr...
TMPK-01402	HLA-A11:01&B2M&KRAS* G12V (VVGAVGVGK) Monomer Protein, Human, MHC (E. coli, His & Avi), Biotinylated	Human	E. coli
	Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-pr...
TMPJ-00510	KRAS Protein, Human, Recombinant (G12C, His)	Human	E. coli
	KRAS Protein, Human, Recombinant (G12C, His) is expressed in E. coli expression system with N-6xHis tag. The predicted molecular weight is 26 KDa and the accession number is AAH13572.1.
------------------------ More ------------------------